Thymosin Alpha-1
Thymic Immunomodulatory Peptide - Thymic peptide studied for immune modulation.
Thymosin Alpha-1 is a peptide originally isolated from the thymus gland, studied extensively for its role in modulating T-cell function and innate immune signalling.
Thymosin Alpha-1 is among the most clinically studied peptides in the catalogue, with approvals in several countries for immune-related indications, though not in the United States. Research centres on its modulation of T-cell maturation and innate immune signalling.
Thymosin Alpha-1 specifications
- Sequence
- 28-amino-acid thymic peptide
- Presentation
- Lyophilised powder
- Documented purity
- 99.69% by HPLC
- Available sizes
- 10mg ($85)
- Archived COA lots
- 3
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- Immune modulation - Investigated for maturation and activity of T-lymphocytes in immunology research.
Reported mechanisms in the literature
- Immune modulation - A thymic peptide studied for maturation and activity of T-lymphocytes and modulation of innate immune signalling. (Goldstein et al.)
Thymosin Alpha-1 frequently asked questions
What is Thymosin Alpha-1?
A 28-amino-acid peptide originally isolated from the thymus, studied for modulating T-cell function and innate immune signalling.
Is it approved for human use?
It is approved for certain uses in some countries but is not an FDA-approved drug in the US. It is supplied here for laboratory research only.
What is it researched for?
Immune modulation, particularly T-lymphocyte maturation and activity, in immunology research.
Documented to 99.69% purity by HPLC · third-party COA every lot · from $85 · For laboratory research use only.